# ROFLUMILAST

NDC: 43547-005
Generic name: roflumilast
Labeler / Manufacturer: Solco Healthcare US, LLC.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20220510

FDA application: ANDA208299

## Active ingredients

- ROFLUMILAST: 500 ug/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"43547-005"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=43547-005
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4251c764-7224-4f94-9de7-b6c76cb1f5cd